Bachem to show TIDE leadership at four European events

Bubendorf, Switzerland: – Leading CDMO Bachem AG will bring its world leadership in small molecule technologies and therapeutics to a series of events across Europe during spring 2026.

Bachem will form a prominent presence at the CRISPR conference in Denmark in mid-April, followed by the Swiss Biotech Day, DDF Summit in Germany, and the LSX Nordic Conference in Copenhagen, all during May.

CRISPR Medicine Conference 2026

Between April 14 and 16, Bachem will attend the CRISPRMED26 conference in Copenhagen, devoted to therapeutics based on use of the CRISPR-Cas9 gene editing tool that has revolutionized genomics and medicine by allowing scientists to precisely cut and modify DNA sequences.

Bachem Business Development Manager Dr. Daniel Bachmann will be on site at the CPH Conference Center throughout the conference and will also take part in the online activities of this hybrid event.  He will be ready to connect, share insights and discuss collaboration opportunities on advancing CRISPR therapeutics.

Swiss Biotech Day 2026

In early May, Bachem will be part of the Swiss Biotech Day at the Congress Center Basel, close to its Bubendorf world headquarters. Bachem has become a recognized presence at the event that provides an annual platform for the Swiss biotech community to network, exchange ideas and explore advances in R&D, manufacturing, data management, AI and innovative financing.

Bachem’s team at the two-day event opening May 4 will be ready to meet and connect with colleagues in Basel and share ways in which the company support peptide and oligomer development needs.

DDF Summit 2026

A fortnight later, Bachem will be in Berlin for the 2026 Global Drug Delivery and Formulation Summit DDF Summit devoted to biologics, devices, technology and innovation.

Bachem is a commercial partner of the DDF Summit and will also be an exhibitor at the three-day event from May 18, with a booth in the Exhibition Zone at the Maritim proArte Hotel in central Berlin.

LSX Nordic Congress 2026

At almost the same time, Bachem will also return to Copenhagen for LSX Nordic Congress, the leading partnering, strategy, and investment event for the Nordic and Baltic life sciences community.

Senior Business Development Manager Bernd Raschack will represent Bachem at the two-day event, opening May 19 at the Radisson Blu Scandinavia Hotel.

Mr. Raschack will be active across the conference’s various networking opportunities and 1-1 meeting platforms to build strategic relationships and explore new growth opportunities.

About Bachem

Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company, which has over 50 years of experience and expertise, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services.

Bachem operates internationally with headquarters in Switzerland and locations in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange.

For further information, see www.bachem.com

Resources

Learn more about the events at:

CRISPR Medicine Conference 2026
Swiss Biotech Day 2026
DDF Summit 2026
LSX Nordic Congress 2026
Click on Bachems News to see latest News & Events.